1. Home
  2. NA vs GRDX Comparison

NA vs GRDX Comparison

Compare NA & GRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Labs Ltd

NA

Nano Labs Ltd

HOLD

Current Price

$0.81

Market Cap

30.1M

Sector

Technology

ML Signal

HOLD

Logo GridAI Technologies Corp.

GRDX

GridAI Technologies Corp.

HOLD

Current Price

$3.22

Market Cap

33.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NA
GRDX
Founded
2019
N/A
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.1M
33.2M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
NA
GRDX
Price
$0.81
$3.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.2K
★ 147.2K
Earning Date
08-28-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 21.95
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$1.87
52 Week High
$4.49
$6.93

Technical Indicators

Market Signals
Indicator
NA
GRDX
Relative Strength Index (RSI) 20.41 36.24
Support Level N/A $3.23
Resistance Level $2.06 $4.19
Average True Range (ATR) 0.20 0.79
MACD -0.04 -0.26
Stochastic Oscillator 7.53 26.36

Price Performance

Historical Comparison
NA
GRDX

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

About GRDX GridAI Technologies Corp.

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: